Small Molecules Suppressors of APOE Gene Expression and Cerebral Vascular Amyloid Pathology
Invention type: Technology
/
Case number: #22991P
The present disclosure provides methods of inhibiting amyloid synthesis in a subject using small molecule inhibitors The invention also includes methods of treating disease associated with amyloid synthesis, such as Alzheimer's disease. The small molecule inhibitors disclosed herein are compounds which are non-immunosuppressant cyclosporin including the pharmaceutically acceptable salts thereof.
Researchers
Li-Huei Tsai
/
Joel Blanchard
Departments: DLC Heads Science
Technology Areas: Therapeutics: Small Molecules
Impact Areas: Healthy Living
-
small molecules suppressors of apoe gene expression and cerebral vascular amyloid pathology
Patent Cooperation Treaty | Published application -
small molecule suppressors of apoe gene expression and cerebral vascular amyloid pathology
United States of America | Published application
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.